L&S Knock-Out MRK 12.06.2024/ DE000LX3QQD7 /
5/20/2024 10:58:28 PM | Chg.-0.01 | Bid10:58:28 PM | Ask10:58:28 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.51EUR | -1.92% | 0.51 Bid Size: - |
0.52 Ask Size: - |
MERCK KGAA O.N. | 115.00 EUR | 6/12/2024 | Call |
GlobeNewswire
5/20
Bionomics to Present at the 2024 American Society of Clinical Psychopharmacology Annual Meeting
GlobeNewswire
5/7
CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire
5/6
Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire
3/4
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
12/21/2023
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
12/14/2023
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
10/17/2023
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA